Operation Warp Speed Woodcock
Department of health and human service released a statement that announced operation warp speeds goal is to produce and deliver 300 million doses of safe and effective vaccines with.
Operation warp speed woodcock. Response to covid 19. As a result of operation warp speed pfizer announced on monday that its vaccine is more than 90 effective. In a major reorganization intended to better align fdas activities with the national effort to develop covid 19 countermeasures janet woodcock is temporarily stepping away from her position as director of fdas center for drug evaluation and research and peter marks is stepping away from his role as lead of vaccines at operation warp speed. Woodcock who recused herself from fdas approval decision is leading owss effort on therapeutics development.
In july pfizer got a 195 billion deal with the governments operation warp speed the multiagency effort to rush a vaccine to market to deliver 100 million doses of the vaccine. At the same time biologics center director peter marks will step away from the administrations vaccine project which he helped stand up fda commissioner stephen hahn said friday may 22. Diagnosis stats weekly newsletter about the. Operation warp speed is a public private partnership to facilitate at an unprecedented pace the development manufacturing and distribution of covid 19 countermeasures between components of hhs including cdc fda nih and the biomedical advanced research and development authority barda.
The department of defense. Woodcock will be detailed to fdas office of the commissioner. Janet woodcock the head of the fdas center for drug evaluation and research. And other federal agencies including the department of agriculture the department of energy and the department of veterans affairs.
In this audio interview conducted on november 9 2020 the editors are joined by dr. Operation warp speed ows food and drug administration fda centers for drug evaluation and research director janet woodcock discussed operation warp speed ows. Fda stalwart janet woodcock will temporarily step aside as the director of the agencys drug approval division to focus on the covid 19 work. Janet woodcock of operation warp speed to discuss the pace of discovery in the us.